TMPRSS11D and anaphylaxis: Lyons et al. reported a 12.2% (10/82) prevalence of HαT in a U.S. cohort of patients with SM, regardless of baseline serum tryptase (bST) levels or a history of atopy, venom allergy, or anaphylaxis (16).